Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets

被引:2
作者
Shrivastava, B. [1 ]
Baghel, U. S. [1 ]
Sahu, M. [2 ]
机构
[1] Jaipur Natl Univ, Sch Pharmaceut Sci, Jaipur 302025, Rajasthan, India
[2] Torent Pharmaceut Pvt Ltd, Ahmadabad 380009, India
关键词
Miglitol; RP-HPLC; stability indicating and method validation; MASS-SPECTROMETRY; HUMAN PLASMA;
D O I
10.4103/0250-474X.84594
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A selective and sensitive, stability-indicating reverse phase high performance liquid chromatography method has been first developed and validated for the estimation of miglitol in bulk and tablet dosages form. Samples were separated on a prepacked, Inertsil amino C-18 column (150x4.6 mm i.d.) using a mobile phase comprised of acetonitrile and monobasic sodium phosphate pH 7.5 (80: 20, v/v) delivered at 1.5 ml/min flow rate. Detection was performed on a SPD-20A prominence UV/Vis detector at 220 nm. The retention time for miglitol was 13.93 +/- 0.0367. The method was validated in terms of linearity, precision, accuracy, ruggedness, and specificity, limit of detection and limit of quantification. The linearity (r(2)) and percentage recoveries of miglitol were 0.9986 and 99.85%. This method is suitable for routine estimation of miglitol in bulk and tablet dosages form.
引用
收藏
页码:781 / 784
页数:4
相关论文
共 7 条
[1]   Simultaneous analysis of polyhydroxylated alkaloids by capillary electrophoresis using borate complexation and evaluation of sweeping technique for sensitivity improvement [J].
Cahours, X ;
Daali, Y ;
Cherkaoui, S ;
Veuthey, JL .
CHROMATOGRAPHIA, 2002, 55 (3-4) :211-216
[2]  
Davis SN., 2001, GOODMAN GILMANS PHAR, V10th, P1701
[3]  
Ibrahim F A, 2007, Int J Biomed Sci, V3, P20
[4]  
ICH Harmonised Tripartite Guideline, 2005, VAL AN PROC TEXT MET
[5]   Determination of miglitol chromatography/tandem in human plasma by liquid mass spectrometry [J].
Li, Xin ;
Wang, Yingwu ;
Wang, Jiang ;
Fawcett, J. Paul ;
Zhao, Limei ;
Gu, Jingkai .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2007, 21 (02) :247-251
[6]  
Nirogi RVS, 2006, ARZNEIMITTEL-FORSCH, V56, P328
[7]  
[王峰 Wang Feng], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P51